Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

MLA

Trask, Peter C., et al. “Health-Related Quality of Life of Bosutinib (SKI-606) in Imatinib-Resistant or Imatinib-Intolerant Chronic Phase Chronic Myeloid Leukemia.” Leukemia Research, vol. 36, no. 4, Apr. 2012, pp. 438–42. EBSCOhost, https://doi.org/10.1016/j.leukres.2011.10.011.

APA

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., & Kim, D.-W. (2012). Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia. Leukemia Research, 36(4), 438–442. https://doi.org/10.1016/j.leukres.2011.10.011

Chicago

Trask, Peter C., David Cella, Nadine Besson, Virginia Kelly, Tamás Masszi, and Dong-Wook Kim. 2012. “Health-Related Quality of Life of Bosutinib (SKI-606) in Imatinib-Resistant or Imatinib-Intolerant Chronic Phase Chronic Myeloid Leukemia.” Leukemia Research 36 (4): 438–42. doi:10.1016/j.leukres.2011.10.011.